Dobutamine is a sympathomimetic drug used in the treatment of heart failure and cardiogenic shock. Its primary mechanism is direct stimulation of β1 receptors of the sympathetic nervous system. References: Lv MY, Deng SL, Long XF. rhBNP therapy can improve clinical outcomes and reduce in-hospital mortality compared with dobutamine in heart failure patients: a meta-analysis. Br J Clin Pharmacol. 2016 Jan;81(1):174-85. doi: 10.1111/bcp.12788. Epub 2015 Nov 28. Review. PubMed PMID: 26382927; PubMed Central PMCID: PMC4693581.

纯度：≥98%

CAS：49745-95-1